Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers

NCT04438837 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

582

Enrollment

OTHER

Sponsor class

Conditions

Coronavirus Disease 2019 (COVID-19)
Post-Exposure Prophylaxis

Interventions

DRUG: Hydroxychloroquine

Sponsor

Rambam Health Care Campus